Abstract
The roles of galanin in central nervous system (CNS) development and the normal adult CNS have been extensively reviewed in this volume and elsewhere. There is also ample evidence that galanin expression is induced following neural injury in the CNS, and has neuroprotective properties separate from its role in normal physiology. Although strong injury-mediated up-regulation of galanin occurs in neurons, there is increasing evidence, accumulated over almost two decades, that glial cells can express galanin in the injured brain and during white matter development. In this chapter, we review the available evidence and canvas the potential functional significance of glial galanin expression.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Cortés R, Ceccatelli S, Schalling M, Hökfelt T (1990) Differential effects of intracerebroventricular colchicine administration on the expression of mRNAs for neuropeptides and neurotransmitter enzymes, with special emphasis on galanin: an in situ hybridization study. Synapse 6:369–391
Kreutzberg GW (1969) Neuronal dynamics and axonal flow. IV. Blockage of intra-axonal enzyme transport by colchicine. Proc Natl Acad Sci USA 62:722–728
Xu Z, Cortés R, Villar M, Morino P, Castel MN, Hökfelt T (1992) Evidence for upregulation of galanin synthesis in rat glial cells in vivo after colchicine treatment. Neurosci Lett 145:185–188
Calzà L, Giardino L, Hökfelt T (1998) Thyroid hormone-dependent regulation of galanin synthesis in neurons and glial cells after colchicine administration. Neuroendocrinology 68:428–436
Ubink R, Calzà L, Hökfelt T (2003) ‘Neuro’-peptides in glia: focus on NPY and galanin. Trends Neurosci 26:604–609
Shen P-J, Larm JA, Gundlach AL (2003) Expression and plasticity of galanin systems in cortical neurons, oligodendrocyte progenitors and proliferative zones of normal brain and after spreading depression. Eur J Neurosci 18:1362–1376
Staugaitis SM, Trapp BD (2009) NG2 positive glia in the human central nervous system. Neuron Glia Biol 29:1–10
Zea Longa E, Weinstein PR, Carlson S, Cummins R (1989) Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20:84–91
Wraith DC, Pope RJ, Butzkueven H, Holder H, Vanderplank P, Lowrey P, Day MJ, Gundlach AL, Kilpatrick TJ, Scolding N et al (2009) A role for galanin in human and experimental inflammatory demyelination. Proc Natl Acad Sci USA 106:15466–15471
Hwang IK, Yoo KY, Kim DS, Do SG, Oh YS, Kang TC, Han BH, Kim JS, Won MH (2004) Expression and changes of galanin in neurons and microglia in the hippocampus after transient forebrain ischemia in gerbils. Brain Res 1023:193–199
Gresle MM, Shaw G, Jarrott B, Alexandrou EN, Friedhuber A, Kilpatrick TJ, Butzkueven H (2008) Validation of a novel biomarker for acute axonal injury in experimental autoimmune encephalomyelitis. J Neurosci Res 86:3548–3555
Wu Q, Butzkueven H, Gresle M, Kirchhoff F, Friedhuber A, Yang Q, Wang H, Fang K, Lei H, Egan GF et al (2007) MR diffusion changes correlate with ultra-structurally defined axonal degeneration in murine optic nerve. Neuroimage 37:1138–1147
Lang R, Gundlach AL, Kofler B (2007) The galanin peptide family: receptor pharmacology, pleiotropic biological actions, and implications in health and disease. Pharmacol Ther 115:177–207
Trotter J, Karram K, Nishiyama A (2010) NG2 cells: properties, progeny and origin. Brain Res Rev 63:72–82
Elliott-Hunt CR, Marsh B, Bacon A, Pope R, Vanderplank P, Wynick D (2004) Galanin acts as a neuroprotective factor to the hippocampus. Proc Natl Acad Sci USA 101:5105–5110
Burazin TCD, Gundlach AL (1998) Inducible galanin and GalR2 receptor system in motor neuron injury and regeneration. J Neurochem 71:879–882
Elliott-Hunt CR, Pope RJ, Vanderplank P, Wynick D (2007) Activation of the galanin receptor 2 (GalR2) protects the hippocampus from neuronal damage. J Neurochem 100:780–789
Su Y, Ganea D, Peng X, Jonakait GM (2003) Galanin down-regulates microglial tumor necrosis factor-alpha production by a post-transcriptional mechanism. J Neuroimmunol 134:52–60
Shen P-J, Yuan C-G, Ma J, Cheng S, Yao M, Turnley AM, Gundlach AL (2005) Galanin in neuro(glio)genesis: expression of galanin and receptors by progenitor cells in vivo and in vitro and effects of galanin on neurosphere proliferation. Neuropeptides 39:201–205
Krzan M, Stenovec M, Kreft M, Pangrsic T, Grilc S, Haydon PG, Zorec R (2003) Calcium-dependent exocytosis of atrial natriuretic peptide from astrocytes. J Neurosci 23:1580–1583
Wiggins AK, Shen P-J, Gundlach AL (2003) Atrial natriuretic peptide expression is increased in rat cerebral cortex following spreading depression: possible contribution to SD-induced neuroprotection. Neuroscience 118:715–726
McKenzie JC, Juan YW, Thomas CR, Berman NE, Klein RM (2001) Atrial natriuretic peptide-like immunoreactivity in neurons and astrocytes of human cerebellum and inferior olivary complex. J Histochem Cytochem 49:1453–1467
Butzkueven H (2008) Leukemia inhibitory factor regulates galanin secretion in vitro and in vivo. Gordon Conference on Myelin Biology, Il Ciocco, Italy
Aloisi F, Rosa S, Testa U, Bonsi P, Russo G, Peschle C, Levi G (1994) Regulation of leukemia inhibitory factor synthesis in cultured human astrocytes. J Immunol 152:5022–5031
Banner LR, Patterson PH (1994) Major changes in the expression of the mRNAs for cholinergic differentiation factor/leukemia inhibitory factor and its receptor after injury to adult preipheral nerves and ganglia. Proc Natl Acad Sci USA 91:7109–7113
Cheema SS, Richards L, Murphy M, Bartlett PF (1994) Leukemia inhibitory factor prevents the death of axotomised sensory neurons in the dorsal root ganglia of the neonatal rat. J Neurosci Res 37:213–218
Sendtner M, Götz R, Holtmann B, Escary J, Masu Y, Carroll P, Wolf E, Brem G, Brület P, Thoenen H (1996) Cryptic physiological trophic support of motoneurons by LIF revealed by double gene targeting of CNTF and LIF. Curr Biol 6:686–694
Butzkueven H, Zhang JG, Soilu-Hanninen M, Hochrein H, Chionh F, Shipham KA, Emery B, Turnley AM, Petratos S, Ernst M et al (2002) LIF receptor signaling limits immune-mediated demyelination by enhancing oligodendrocyte survival. Nat Med 8:613–619
Sun Y, Zigmond RE (1996) Involvement of leukemia inhibitory factor in the increases in galanin and vasoactive intestinal peptide mRNA and the decreases in neuropeptide Y and tyrosine hydroxylase mRNA in sympathetic neurons after axotomy. J Neurochem 67:1751–1760
Binder MD, Cate HS, Prieto AL, Kemper D, Butzkueven H, Gresle MM, Cipriani T, Jokubaitis VG, Carmeliet P, Kilpatrick TJ (2008) Gas6 deficiency increases oligodendrocyte loss and microglial activation in response to cuprizone-induced demyelination. J Neurosci 28:5195–5206
Bulaj G, Green BR, Lee HK, Robertson CR, White K, Zhang L, Sochanska M, Flynn SP, Scholl EA, Pruess TH et al (2008) Design, synthesis, and characterization of high-affinity, systemically-active galanin analogues with potent anticonvulsant activities. J Med Chem 51:8038–8047
Detlev B (2007) Cell and gene therapies for refractory epilepsy. Curr Neuropharmacol 5:115–125
Hanson LR, Frey WHI (2008) Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease. BMC Neurosci 9(Suppl 3):S5
Acknowledgements
The authors would like to acknowledge the support of NHMRC (Australia) and the US Multiple Sclerosis Society and the many colleagues who contributed to the research reviewed in this article.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Basel AG
About this chapter
Cite this chapter
Butzkueven, H., Gundlach, A.L. (2010). Galanin in Glia: Expression and Potential Roles in the CNS. In: Hökfelt, T. (eds) Galanin. Experientia Supplementum, vol 102. Springer, Basel. https://doi.org/10.1007/978-3-0346-0228-0_6
Download citation
DOI: https://doi.org/10.1007/978-3-0346-0228-0_6
Published:
Publisher Name: Springer, Basel
Print ISBN: 978-3-0346-0227-3
Online ISBN: 978-3-0346-0228-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)